MCCC2
Basic information
Region (hg38): 5:71579531-71658706
Links
Phenotypes
GenCC
Source:
- 3-methylcrotonyl-CoA carboxylase deficiency (Supportive), mode of inheritance: AR
- 3-methylcrotonyl-CoA carboxylase deficiency (Definitive), mode of inheritance: AR
- 3-methylcrotonyl-CoA carboxylase 2 deficiency (Definitive), mode of inheritance: AR
- 3-methylcrotonyl-CoA carboxylase 2 deficiency (Strong), mode of inheritance: AR
- 3-methylcrotonyl-CoA carboxylase 2 deficiency (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
3-Methylcrotonyl-CoA carboxylase 2 deficiency | AR | Biochemical | Therapy may not be necessary/effective in some individuals, but medical (eg, carnitine, glycine) and dietary (eg, low protein, leucine restricted) therapy may be beneficial in some individuals; Precautions in the setting of stressors such as viral illnesses may be beneficial | Biochemical; Neurologic | 7128647; 1293382; 8598650; 8831079; 9544913; 11181649; 11170888; 15877210; 16835865; 17968484; 22030835; 22264772; 22642865; 25356967 |
ClinVar
This is a list of variants' phenotypes submitted to
- 3-methylcrotonyl-CoA_carboxylase_2_deficiency (657 variants)
- not_provided (109 variants)
- Methylcrotonyl-CoA_carboxylase_deficiency (63 variants)
- not_specified (56 variants)
- Inborn_genetic_diseases (47 variants)
- MCCC2-related_disorder (32 variants)
- Spinal_muscular_atrophy,_type_IV (1 variants)
- Autism_spectrum_disorder (1 variants)
- See_cases (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MCCC2 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000022132.5. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 16 | 155 | 173 | |||
missense | 71 | 197 | 281 | |||
nonsense | 14 | 28 | 42 | |||
start loss | 1 | 1 | ||||
frameshift | 25 | 23 | 49 | |||
splice donor/acceptor (+/-2bp) | 36 | 42 | ||||
Total | 51 | 158 | 215 | 162 | 2 |
Highest pathogenic variant AF is 0.000670395
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MCCC2 | protein_coding | protein_coding | ENST00000340941 | 17 | 71417 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
4.51e-11 | 0.937 | 125674 | 0 | 74 | 125748 | 0.000294 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.306 | 298 | 313 | 0.951 | 0.0000164 | 3640 |
Missense in Polyphen | 122 | 137.71 | 0.88591 | 1633 | ||
Synonymous | 0.0302 | 112 | 112 | 0.996 | 0.00000607 | 1097 |
Loss of Function | 2.04 | 22 | 35.0 | 0.628 | 0.00000199 | 409 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000724 | 0.000724 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000598 | 0.000544 |
Finnish | 0.000185 | 0.000185 |
European (Non-Finnish) | 0.000237 | 0.000237 |
Middle Eastern | 0.000598 | 0.000544 |
South Asian | 0.000490 | 0.000490 |
Other | 0.000326 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Carboxyltransferase subunit of the 3-methylcrotonyl-CoA carboxylase, an enzyme that catalyzes the conversion of 3- methylcrotonyl-CoA to 3-methylglutaconyl-CoA, a critical step for leucine and isovaleric acid catabolism. {ECO:0000269|PubMed:17360195}.;
- Disease
- DISEASE: 3-methylcrotonoyl-CoA carboxylase 2 deficiency (MCC2D) [MIM:210210]: An autosomal recessive disorder of leucine catabolism. The phenotype is variable, ranging from neonatal onset with severe neurological involvement to asymptomatic adults. There is a characteristic organic aciduria with massive excretion of 3- hydroxyisovaleric acid and 3-methylcrotonylglycine, usually in combination with a severe secondary carnitine deficiency. {ECO:0000269|PubMed:11170888, ECO:0000269|PubMed:11181649, ECO:0000269|PubMed:11406611, ECO:0000269|PubMed:16010683, ECO:0000269|PubMed:17968484, ECO:0000269|PubMed:21071250, ECO:0000269|PubMed:22150417, ECO:0000269|PubMed:22264772, ECO:0000269|PubMed:22642865, ECO:0000269|PubMed:25382614, ECO:0000269|PubMed:27601257}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Valine, leucine and isoleucine degradation - Homo sapiens (human);3-Methylglutaconic Aciduria Type I;Valine, Leucine and Isoleucine Degradation;2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency;Isovaleric Aciduria;3-Methylcrotonyl Coa Carboxylase Deficiency Type I;Propionic Acidemia;Maple Syrup Urine Disease;3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency;Isobutyryl-coa dehydrogenase deficiency;3-hydroxyisobutyric aciduria;3-hydroxyisobutyric acid dehydrogenase deficiency;Isovaleric acidemia;Methylmalonate Semialdehyde Dehydrogenase Deficiency;Methylmalonic Aciduria;3-Methylglutaconic Aciduria Type IV;3-Methylglutaconic Aciduria Type III;Beta-Ketothiolase Deficiency;Biotin transport and metabolism;Branched-chain amino acid catabolism;Metabolism of amino acids and derivatives;leucine degradation;Metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;Valine, leucine and isoleucine degradation;Valine Leucine Isoleucine degradation
(Consensus)
Recessive Scores
- pRec
- 0.180
Intolerance Scores
- loftool
- 0.206
- rvis_EVS
- -0.22
- rvis_percentile_EVS
- 37.43
Haploinsufficiency Scores
- pHI
- 0.0357
- hipred
- N
- hipred_score
- 0.237
- ghis
- 0.501
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.977
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Mccc2
- Phenotype
Gene ontology
- Biological process
- leucine catabolic process;biotin metabolic process;coenzyme A metabolic process;protein heterooligomerization
- Cellular component
- 3-methylcrotonyl-CoA carboxylase complex, mitochondrial;mitochondrion;mitochondrial matrix;cytosol;methylcrotonoyl-CoA carboxylase complex
- Molecular function
- methylcrotonoyl-CoA carboxylase activity;protein binding;ATP binding